These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 823053)

  • 1. [Studies on the TRH test on the patients with Graves' disease during the treatment with antithyroid drug (author's transl)].
    Enomoto K; Inoue K; Enomoto H
    Nihon Naibunpi Gakkai Zasshi; 1975 Dec; 51(12):1052-64. PubMed ID: 823053
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of chronic iodine administration on thyroid status in euthyroid subjects previously treated with antithyroid drugs for Graves' hyperthyroidism.
    Roti E; Gardini E; Minelli R; Bianconi L; Salvi M; Gavaruzzi G; Braverman LE
    J Clin Endocrinol Metab; 1993 Apr; 76(4):928-32. PubMed ID: 7682562
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of thyrotropin-releasing hormone on serum thyroid hormones: a study in the patients with untreated and treated Graves' disease and subacute thyroiditis.
    Sato A; Yamada T; Aizawa T; Ichikawa K; Komiya I; Takasu N; Takemura Y
    J Clin Endocrinol Metab; 1995 Jul; 80(7):2173-7. PubMed ID: 7608274
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reappraisal of the 3,5,3'-triiodothyronine-suppression test in the prediction of long term outcome of antithyroid drug therapy in patients with hyperthyroid Graves' disease.
    Yamada T; Koizumi Y; Sato A; Hashizume K; Aizawa T; Takasu N; Nagata H
    J Clin Endocrinol Metab; 1984 Apr; 58(4):676-80. PubMed ID: 6421866
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pituitary-thyroid feedback regulation in patients with Graves' disease during antithyroid drug therapy.
    Yamada T; Takasu N; Sato A; Aizawa T; Koizumi Y
    J Clin Endocrinol Metab; 1982 Jan; 54(1):83-8. PubMed ID: 6798061
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Fluctuations in the titers of anti-thyroid hormone and anti-thyroglobulin antibodies in 4 cases of Graves' disease during long-term treatment period].
    Komaki T; Sakata S; Nakamura S; Matsuda M; Kojima N; Takuno H; Miura K
    Nihon Naibunpi Gakkai Zasshi; 1989 Jul; 65(7):627-39. PubMed ID: 2583311
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pituitary-thyroid regulation in euthyroid patients with Graves' disease previously treated with antithyroid drugs.
    Buerklin EM; Schimmel M; Utiger RD
    J Clin Endocrinol Metab; 1976 Aug; 43(2):419-27. PubMed ID: 59733
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Studies of thyroid function and immune parameters in patients with hyperthyroid Graves' disease in remission.
    Murakami M; Koizumi Y; Aizawa T; Yamada T; Takahashi Y; Watanabe T; Kamoi K
    J Clin Endocrinol Metab; 1988 Jan; 66(1):103-8. PubMed ID: 3121661
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Changes in responsivity to TRH test and T3-suppression test after surgical treatment of hyperthyroidism (author's transl)].
    Tamai H; Fujino R; Shizume K; Kuma K; Suematsu H
    Nihon Naibunpi Gakkai Zasshi; 1975 Dec; 51(12):985-96. PubMed ID: 823054
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Relation of TRH test to thyroidal suppression test by triiodothyronine in patients with hyperthyroidism under treatment with antithyroid drugs (author's transl)].
    Kuribayashi T; Yuji S; Yajima Y
    Nihon Naibunpi Gakkai Zasshi; 1975 Feb; 51(2):103-8. PubMed ID: 50954
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [TRH and T3 suppression tests after 131I therapy of thyrotoxicosis (author's transl)].
    Tamai H; Tsushimi T; Shizume K; Kuma K; Suematsu H
    Nihon Naibunpi Gakkai Zasshi; 1976 Mar; 52(3):232-42. PubMed ID: 823056
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hyperthyroidism caused by a pituitary thyrotrophin-secreting tumour with excessive secretion of thyrotrophin-releasing hormone and subsequently followed by Graves' disease in a middle-aged woman.
    Kamoi K; Mitsuma T; Sato H; Yokoyama M; Washiyama K; Tanaka R; Arai O; Takasu N; Yamada T
    Acta Endocrinol (Copenh); 1985 Nov; 110(3):373-82. PubMed ID: 3934894
    [TBL] [Abstract][Full Text] [Related]  

  • 13. T4 suppression test involving 24-hour thyroidal 131I uptake in patients with Graves' disease compared to the T3 suppression test.
    Kobayashi I; Ishii H; Mori M; Kobayashi S
    Endocrinol Jpn; 1984 Jun; 31(3):263-70. PubMed ID: 6548699
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Studies on the T3 suppression test by the 24-hour thyroidal 131I uptake in patients with Graves' disease: comparison of the effects of propylthiouracil and methylmercaptoimidazole.
    Kobayashi I; Maruta S; Mori M; Ishii H; Ishihara H; Iriuchijima T; Takahashi M; Shimomura Y; Fukuda H
    Endocrinol Jpn; 1983 Aug; 30(4):491-7. PubMed ID: 6200318
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The thyrotrophin response to thyrotrophin releasing hormone during treatment in patients with Graves' disease.
    Haug E; Frey HM; Sand T
    Acta Endocrinol (Copenh); 1977 Jun; 85(2):335-44. PubMed ID: 405834
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Serum thyroid hormones and TSH response to TRH during treatment of Graves' disease by carbimazole (author's transl)].
    Lorcy Y; Heim J; Auvray E; Allannic H
    Ann Endocrinol (Paris); 1979; 40(4):441-2. PubMed ID: 117739
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical studeis on the regulatory system of thyroid hormone secretion and serum triiodothyronine. Part III. Studies on thyroid hormone change and its relationship when TSH in cases with subclinical hypothyroidism (Hashimoto's thyroiditis and 131I treated Graves' disease)].
    Takeda Y
    Nihon Naibunpi Gakkai Zasshi; 1975 Feb; 51(2):85-97. PubMed ID: 808432
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Variation of the thyrotropin-releasing-hormone (TRH) stimulated thyrotropin (TSH) response in comparison with the tyhroid-gland-suppression test and the triiodothyronine (T3) and thyroxine (T4) blood levels in the so-called euthyroid endocrine ophthalmopathy].
    Wenzel KW
    Endokrinologie; 1975 Sep; 66(1):67-73. PubMed ID: 1243821
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sensitivity of thyroids to endogenous thyrotrophin in patients with Graves' disease.
    Tamai H; Nagai K; Uehata S; Komaki G; Kiyohara K; Miyauchi A; Kuma K; Kumagai LF; Nagataki S
    Exp Clin Endocrinol; 1990 Dec; 96(3):279-87. PubMed ID: 2128053
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thyroidal response to an increase or decrease of endogenous TSH in patients with hyperthyroidism and its correlation with TSH binding inhibiting immunoglobulin.
    Katakura M; Koizumi Y; Aizawa T; Takasu N; Yamada T; Yukimura Y; Nagata H
    Clin Exp Pharmacol Physiol; 1986 May; 13(5):407-15. PubMed ID: 2874908
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.